139 related articles for article (PubMed ID: 21242959)
1. The role of CD44 in the acute and resolution phase of the host response during pneumococcal pneumonia.
van der Windt GJ; Hoogendijk AJ; de Vos AF; Kerver ME; Florquin S; van der Poll T
Lab Invest; 2011 Apr; 91(4):588-97. PubMed ID: 21242959
[TBL] [Abstract][Full Text] [Related]
2. CD44 deficiency leads to enhanced neutrophil migration and lung injury in Escherichia coli pneumonia in mice.
Wang Q; Teder P; Judd NP; Noble PW; Doerschuk CM
Am J Pathol; 2002 Dec; 161(6):2219-28. PubMed ID: 12466136
[TBL] [Abstract][Full Text] [Related]
3. CD44 deficiency is associated with increased bacterial clearance but enhanced lung inflammation during Gram-negative pneumonia.
van der Windt GJ; Florquin S; de Vos AF; van't Veer C; Queiroz KC; Liang J; Jiang D; Noble PW; van der Poll T
Am J Pathol; 2010 Nov; 177(5):2483-94. PubMed ID: 20864681
[TBL] [Abstract][Full Text] [Related]
4. The receptor for advanced glycation end products impairs host defense in pneumococcal pneumonia.
van Zoelen MA; Schouten M; de Vos AF; Florquin S; Meijers JC; Nawroth PP; Bierhaus A; van der Poll T
J Immunol; 2009 Apr; 182(7):4349-56. PubMed ID: 19299735
[TBL] [Abstract][Full Text] [Related]
5. The endothelial protein C receptor impairs the antibacterial response in murine pneumococcal pneumonia and sepsis.
Schouten M; de Boer JD; Kager LM; Roelofs JJ; Meijers JC; Esmon CT; Levi M; van 't Veer C; van der Poll T
Thromb Haemost; 2014 May; 111(5):970-80. PubMed ID: 24401906
[TBL] [Abstract][Full Text] [Related]
6. Urokinase receptor is necessary for adequate host defense against pneumococcal pneumonia.
Rijneveld AW; Levi M; Florquin S; Speelman P; Carmeliet P; van Der Poll T
J Immunol; 2002 Apr; 168(7):3507-11. PubMed ID: 11907112
[TBL] [Abstract][Full Text] [Related]
7. Granzyme A impairs host defense during Streptococcus pneumoniae pneumonia.
van den Boogaard FE; van Gisbergen KP; Vernooy JH; Medema JP; Roelofs JJ; van Zoelen MA; Endeman H; Biesma DH; Boon L; Van't Veer C; de Vos AF; van der Poll T
Am J Physiol Lung Cell Mol Physiol; 2016 Aug; 311(2):L507-16. PubMed ID: 27343190
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin impairs host defense during pneumococcal pneumonia.
van der Windt GJ; Hoogendijk AJ; Schouten M; Hommes TJ; de Vos AF; Florquin S; van der Poll T
J Infect Dis; 2011 Jun; 203(12):1850-8. PubMed ID: 21606543
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the platelet-activating factor receptor in host defense against Streptococcus pneumoniae during postinfluenza pneumonia.
van der Sluijs KF; van Elden LJ; Nijhuis M; Schuurman R; Florquin S; Shimizu T; Ishii S; Jansen HM; Lutter R; van der Poll T
Am J Physiol Lung Cell Mol Physiol; 2006 Jan; 290(1):L194-9. PubMed ID: 16100290
[TBL] [Abstract][Full Text] [Related]
10. Activation of neutrophils and inhibition of the proinflammatory cytokine response by endogenous granulocyte colony-stimulating factor in murine pneumococcal pneumonia.
Knapp S; Hareng L; Rijneveld AW; Bresser P; van der Zee JS; Florquin S; Hartung T; van der Poll T
J Infect Dis; 2004 Apr; 189(8):1506-15. PubMed ID: 15073689
[TBL] [Abstract][Full Text] [Related]
11. Myeloid-related protein-8/14 facilitates bacterial growth during pneumococcal pneumonia.
Achouiti A; Vogl T; Endeman H; Mortensen BL; Laterre PF; Wittebole X; van Zoelen MA; Zhang Y; Hoogerwerf JJ; Florquin S; Schultz MJ; Grutters JC; Biesma DH; Roth J; Skaar EP; van 't Veer C; de Vos AF; van der Poll T
Thorax; 2014 Nov; 69(11):1034-42. PubMed ID: 25179663
[TBL] [Abstract][Full Text] [Related]
12. Endogenous tissue factor pathway inhibitor has a limited effect on host defence in murine pneumococcal pneumonia.
van den Boogaard FE; van 't Veer C; Roelofs JJ; Meijers JC; Schultz MJ; Broze GJ; van der Poll T
Thromb Haemost; 2015 Jul; 114(1):115-22. PubMed ID: 25832548
[TBL] [Abstract][Full Text] [Related]
13. Protease-activated receptor-1 impairs host defense in murine pneumococcal pneumonia: a controlled laboratory study.
Schouten M; van't Veer C; Roelofs JJ; Levi M; van der Poll T
Crit Care; 2012 Dec; 16(6):R238. PubMed ID: 23270594
[TBL] [Abstract][Full Text] [Related]
14. Mast cells impair host defense during murine Streptococcus pneumoniae pneumonia.
van den Boogaard FE; Brands X; Roelofs JJ; de Beer R; de Boer OJ; van 't Veer C; van der Poll T
J Infect Dis; 2014 Nov; 210(9):1376-84. PubMed ID: 24823624
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense.
Knapp S; Wieland CW; van 't Veer C; Takeuchi O; Akira S; Florquin S; van der Poll T
J Immunol; 2004 Mar; 172(5):3132-8. PubMed ID: 14978119
[TBL] [Abstract][Full Text] [Related]
16. Protease activated receptor 4 limits bacterial growth and lung pathology during late stage Streptococcus pneumoniae induced pneumonia in mice.
de Stoppelaar SF; Van't Veer C; van den Boogaard FE; Nieuwland R; Hoogendijk AJ; de Boer OJ; Roelofs JJ; van der Poll T
Thromb Haemost; 2013 Sep; 110(3):582-92. PubMed ID: 23783078
[TBL] [Abstract][Full Text] [Related]
17. NLRP3 and ASC differentially affect the lung transcriptome during pneumococcal pneumonia.
van Lieshout MH; Scicluna BP; Florquin S; van der Poll T
Am J Respir Cell Mol Biol; 2014 Apr; 50(4):699-712. PubMed ID: 24164497
[TBL] [Abstract][Full Text] [Related]
18. Pneumococcal conjugate vaccine modulates macrophage-mediated innate immunity in pneumonia caused by Streptococcus pneumoniae following influenza.
Mimura K; Kimura S; Kajiwara C; Nakakubo S; Schaller MA; Ishii Y; Standiford TJ; Kunkel SL; Tateda K
Microbes Infect; 2020 Sep; 22(8):312-321. PubMed ID: 31958572
[TBL] [Abstract][Full Text] [Related]
19. Triggering receptor expressed on myeloid cells-1 (TREM-1) improves host defence in pneumococcal pneumonia.
Hommes TJ; Hoogendijk AJ; Dessing MC; Van't Veer C; Florquin S; Colonna M; de Vos AF; van der Poll T
J Pathol; 2014 Aug; 233(4):357-67. PubMed ID: 24752755
[TBL] [Abstract][Full Text] [Related]
20. CD11b limits bacterial outgrowth and dissemination during murine pneumococcal pneumonia.
Rijneveld AW; de Vos AF; Florquin S; Verbeek JS; van der Poll T
J Infect Dis; 2005 May; 191(10):1755-60. PubMed ID: 15838804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
